What is the Future of Health Economics Assessment of Drugs in France?

This article provides an in-depth description of the France’s CEESP structure and working methods, and analyses the impact of health economic assessment on market access of drugs in France, as well as pointing out the areas of uncertainty and the conflicting rules following the introduction of the health economic assessment. Learn more here. (Source: Journal of Market Access & Health Policy, 2015)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
Scientific Research And Development Services Global Market… 06/19/2020
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
Jeff Anderson Joins OPEN Health as European Lead for OPEN VIE… 06/16/2020
Real World Evidence (RWE) Solutions Market by Component,… 02/05/2020
Biomarkers and Companion diagnostics: Payer Insights 09/26/2019
The Future of Personalised Medicine: The Role of Simulation… 01/25/2020